In this article, we identify the top 10 stocks with low volatility to buy now.

The US stock market experienced a turbulent first quarter of 2025, marked by increased volatility and negative returns across the major indices. Uncertainty surrounding the performance of technology stocks, economic data, and trade tensions caused market volatility.

The year began with the revelation of an Artificial Intelligence (AI) software developed in China called DeepSeek. The innovative AI rivalled its US competitors, such as ChatGPT, and was considered revolutionary compared to others, sending shockwaves across the global markets. Reuters reported a global investor sell-off across US indexes, with one of the major tech companies alone losing $593 million in one day. The US government was quick to implement policies aimed at promoting US-listed tech firms, while simultaneously reducing the impact of DeepSeek AI, such as the use of tariffs against trade with Chinese firms.

In February of 2025, the US government’s first round of Tariffs was aimed directly at China in an effort to curb the impact of DeepSeek on the United States’ tech industry. In March, President Trump announced a rate of 54% tariff on Chinese goods, while China retaliated with 34% tariffs on US goods and services. As reported by CNBC, the total tariffs applied on Chinese goods by the United States stand at 145%, as of April 11, 2025, with exemptions on specific sectors such as Technology, Automobiles & Smart Phones. China implemented retaliatory trade tariffs of 125% on American goods and services.

Due to this economic landscape, the uncertainty surrounding interest rates added to market volatility. The Federal Reserve announced it would maintain interest rates between 4.25% and 4.50%. Speaking at a dinner at the Economic Club of Chicago, Federal Reserve Chairman Jerome Powell stated:

“For the time being, we are well positioned to wait for greater clarity before considering any adjustments to our policy stance.”

The US economy is considered to be entering “continuous stagflation”, which is defined as continued inflation with very low growth and high unemployment. The Cboe Volatility Index (aka VIX) is one of the indicators that the Fed monitors as part of the broader tools available to assess market conditions. A VIX of 20 or higher suggests a higher-than-normal level of expected price fluctuations. The VIX is currently at 32.64%.

The current market suggests that investors might want to lean toward low-risk stocks to avoid potential financial pitfalls. Low-volatility stocks are currently outpacing the broader market and proving their strength during uncertain times. After two lackluster years, this strategy has emerged as the top-performing investment theme of 2025 among the 13 tracked by Bloomberg Intelligence. Joe Gilbert, portfolio manager at Integrity Asset Management, made the following comment about the low risk stocks:

“Investors are going to have to live with volatility at least for the remainder of this year. The lower volatility names are the place for investors to hide.”

Given this, we will take a look at some of the best low volatility stocks to invest in.

Our Methodology

In this article, we researched the 20 Companies with the lowest 5-year beta (monthly) between 0.2 and 0.8, using the Yahoo Finance stocks screener. Next, we used Insider Monkey’s Q4 2024 proprietary hedge fund holdings database and identified the 10 most popular hedge fund stocks. The stocks are ranked in ascending order of their hedge fund positions.

At Insider Monkey, we are obsessed with hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

10. Boston Scientific Corporation (NYSE:BSX)

5-Year Monthly Beta: 0.73

No. of Hedge Fund Holders: 96

Boston Scientific Corporation (NYSE:BSX) is a global medical device company focused on developing, manufacturing, and marketing a broad portfolio of solutions across various interventional medical specialties. This includes products such as the WATCHMAN FLX LAAC device, implantable cardiac devices like defibrillators and pacemakers, along with remote patient monitoring systems. BSX ranks tenth on our list of the best low volatility stocks to consider.

Boston Scientific Corporation (NYSE:BSX) has manufacturing facilities in Canada and Research & Development centres in China. These are likely to be impacted by the recent tariffs announced by the US government on Canada and China, and vice versa.

Despite these challenges, Boston Scientific Corporation (NYSE:BSX)’s strategic acquisitions drive its growth and diversification in the healthcare sector. The company completed its takeover of BOLT Medical for $664 million in January. This was followed by buying SoniVie in March for a value of $540 million, entering the renal denervation (RDN) market.

Guided by strong core values, Boston Scientific Corporation (NYSE:BSX) treats over 44 million patients annually. Demonstrating its dedication to advancement, in 2024, the company invested $1.6 billion in research and development, leading to the launch of approximately 100 new products. Boston Scientific Corporation (NYSE:BSX) reported revenue of $4.56 billion in the last quarter of 2024 (up by 22.44%), beating estimates by $139.91 million, and an EPS of $0.70.

9. Johnson & Johnson (NYSE:JNJ)

5-Year Monthly Beta: 0.48

No. of Hedge Fund Holders: 98

Johnson & Johnson (NYSE:JNJ) is a global healthcare company involved in the research, development, manufacture, and sale of a wide range of products. The company operates through two main segments: Innovative Medicine and MedTech. Guided by core values emphasizing caring, innovation, and ethical practices, JNJ has strived to create a healthier future for everyone for over a century now. JNJ is one of the best low volatility stocks to consider.

Johnson & Johnson (NYSE:JNJ) continues to face criticism due to a litigation case related to ovarian cancer in 2009. Reuters reported that a US court in March of 2025 rejected the company’s attempt to settle all lawsuits for $10 billion. The company estimates that trade tariffs on China will also have an impact of $400 million in 2025, as per CNBC.

Regardless of these headwinds, JNJ has a history of strong financial performance in the pharmaceutical industry, with 65% of its income generated from either being the number one or number two market leader in its segments. Johnson & Johnson (NYSE:JNJ) company’s earnings report for Q1 2025 revealed revenue of $21.89 billion, a 2.4% increase YoY. The company provided guidance for the upcoming quarter to the tune of $22.85 billion. JNJ has a history of consistent earnings and dividend payments. This predictability attracts investors seeking stable returns and lower risk, contributing to less price volatility. The company is often considered a “blue-chip” stock, favored by risk-averse investors.